CompanyCore
UK company intelligence
Company profile report
Prepared 04 May 2026
GLOX THERAPEUTICS LIMITED
SC760230 · ltd · incorporated 2023-02-27
1. Company facts
- Status
- active
- Lifecycle
- 🌿 Early-stage — Trading and building — modest revenue, not yet scaled.
- Jurisdiction
- scotland
- Registered office
- John Arbuthnott Building Strathclyde University Of Pharmacy & Biomedical, 161 Cathedral Street, Glasgow, G4 0RE, Scotland
- SIC codes
- 72110 — Research and experimental development on biotechnology; 72190 — Other research and experimental development on natural sciences and engineering
- Accounts next due
- 2026-09-30
- Confirmation statement next due
- 2027-03-12
2. Directors (3 active)
- MURRAY, Michael Stephen, Dr
- director · appointed 2025-02-06 · born 12/1963 (age 63)
- NICKLIN, Paul, Dr
- director · appointed 2025-08-12 · born 1/1967 (age 59)
- WALKER, Daniel, Professor
- director · appointed 2023-10-24 · born 2/1973 (age 53)
Headline verdict
- Opportunity score
- 72/100 (Strong)
- Owner dependency
- moderate — 58/100
- Red flags
- 0 high · 1 medium · 0 low